共 57 条
[1]
Arber DA(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-405
[2]
Orazi A(2015)SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts Blood 126 233-41
[3]
Hasserjian R(2011)Frequent pathway mutations of splicing machinery in myelodysplasia Nature 478 64-9
[4]
Thiele J(2011)Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts N. Engl J Med 365 1384-95
[5]
Borowitz MJ(2020)SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS Blood 136 157-70
[6]
Le Beau MM(2011)Clinical effect of point mutations in myelodysplastic syndromes N. Engl J Med 364 2496-506
[7]
Malcovati L(2014)Landscape of genetic lesions in 944 patients with myelodysplastic syndromes Leukemia 28 241-7
[8]
Karimi M(2019)TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups Leukemia 33 1747-58
[9]
Papaemmanuil E(2020)The Problem of TP53-Mutant MDS/AML Clin Lymphoma Myeloma Leuk 20 S65-S6
[10]
Ambaglio I(2008)Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts Haematologica 93 1712-7